| HOME >> BIOLOGY >> TECHNOLOGY |
ST. JOSEPH, Mich., July 16 /PRNewswire/ -- GeneGo, Inc., a leading provider of software and databases for systems biology and pathway analysis, today announced that the University of Miami Miller School of Medicine has become a certified GeneGo Center of Excellence (COE). Miller School of Medicine researchers will have access to GeneGo's MetaCore, training and advanced support. COE will provide a pathway analysis environment and support for all the school's researchers. They will also act as a training facility for GeneGo in the University of Miami.
"We are looking forward to working with GeneGo as the company provides the kind of forward-looking bioinformatics software that we are excited to use," said Sawsan Khuri, Ph.D., assistant research professor at the Center for Computational Science at the University of Miami Miller School of Medicine. "The technology will be extremely useful for researchers here, especially those at the Miami Project to Cure Paralysis and the Miami Institute for Human Genomics, both of which will benefit greatly from the collaboration with GeneGo as we work toward new scientific breakthroughs."
"The University of Miami has some important thought leaders in this field and we are pleased to be working with them," said Julie Bryant, Vice President of Business Development at GeneGo. "The school of medicine works with one million patients annually and it is encouraging that we can help them to improve their quality of life."
About GeneGo
GeneGo develops systems biology technology for life science research.
The original computational MetaDiscovery(TM) platform allows an integration
and expert analysis of different kinds of experimental data (mRNA
expression, proteomics, metabolomics, microRNA assays and other phenotypic
data) and relevant bioactive chemistry (metabolites, drugs, other
xenobiotics) within the framework of curated biological pathways and
networks. GeneGo's flagship product, MetaCore 4.7(TM), assi
'/>"/>
| SOURCE GeneGo, Inc. Copyright©2008 PR Newswire. All rights reserved |